{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:10:45Z","timestamp":1760015445071},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1053\/j.seminoncol.2007.09.006","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T23:09:18Z","timestamp":1199315358000},"page":"452-459","source":"Crossref","is-referenced-by-count":18,"title":["Genetics: What Advice for Patients Who Present With a Family History of Melanoma?"],"prefix":"10.1053","volume":"34","author":[{"given":"Julia A.","family":"Newton Bishop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelleke A.","family":"Gruis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2007.09.006_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.11360","article-title":"Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia","volume":"107","author":"de Vries","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<62::AID-IJC12>3.0.CO;2-2","article-title":"Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age","volume":"81","author":"La Vecchia","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/oxfordjournals.aje.a117203","article-title":"Heterogeneity of melanoma risk in families of melanoma patients","volume":"140","author":"Aitken","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10552-004-2474-1","article-title":"Familial aggregation of melanoma risks in a large population-based sample of melanoma cases","volume":"15","author":"Begg","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/cncr.20989","article-title":"A cohort study of cancer risk in relation to family histories of cancer in the Utah population database","volume":"103","author":"Kerber","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jnci\/djh080","article-title":"For whom the bell tolls: Susceptibility to common adult cancers in retinoblastoma survivors","volume":"96","author":"Kaye","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: A review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1098-2388(200006)18:4<281::AID-SSU2>3.0.CO;2-Q","article-title":"Genes implicated in hereditary breast cancer syndromes","volume":"18","author":"Tonin","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s00432-002-0360-3","article-title":"p53 Germline mutation in a patient with Li-Fraumeni syndrome and three metachronous malignancies","volume":"128","author":"Potzsch","year":"2002","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib10","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/hmg\/5.10.1663","article-title":"The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma","volume":"5","author":"Valverde","year":"1996","journal-title":"Human Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib11","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/geno.1994.1491","article-title":"Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171","volume":"23","author":"Cannon-Albright","year":"1994","journal-title":"Genomics"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","article-title":"Cellular senescence in naevi and immortalisation in melanoma: A role for p16?","volume":"95","author":"Gray-Schopfer","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0968-0004(98)01236-5","article-title":"The INK4a\/ARF tumor suppressor: One gene\u2014two products\u2014two pathways","volume":"23","author":"Chin","year":"1998","journal-title":"Trends Biochem Sci"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4161\/cc.4.4.1588","article-title":"p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners","volume":"4","author":"Rizos","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib19","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.biocel.2006.02.008","article-title":"The ARF tumour suppressor","volume":"38","author":"Gallagher","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/hmg\/10.1.55","article-title":"A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family","volume":"10","author":"Randerson-Moor","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib21","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","article-title":"A melanoma-associated germline mutation in exon 1beta inactivates p14ARF","volume":"20","author":"Rizos","year":"2001","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib22","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/hmg\/11.11.1273","article-title":"Germline mutation of ARF in a melanoma kindred","volume":"11","author":"Hewitt","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib23","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1038\/sj.onc.1208678","article-title":"A mutation hotspot at the p14ARF splice site","volume":"24","author":"Harland","year":"2005","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00008390-200202000-00008","article-title":"Rarity of CDK4 germline mutations in familial melanoma","volume":"12","author":"Goldstein","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20202","article-title":"A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation","volume":"44","author":"Molven","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/gcc.20238","article-title":"Prevalence of 9p21 deletions in UK melanoma families","volume":"44","author":"Mistry","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM198905253202102","article-title":"Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p","volume":"320","author":"Bale","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/377140","article-title":"Localization of a novel melanoma susceptibility locus to 1p22","volume":"73","author":"Gillanders","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib30","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/89.10.697","article-title":"Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma","volume":"89","author":"Platz","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-199506000-00005","article-title":"CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families","volume":"5","author":"Gruis","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/303001","article-title":"A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families","volume":"67","author":"Ciotti","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/bjc.1990.209","article-title":"Systemic cancer and the FAMMM syndrome","volume":"61","author":"Bergman","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006676-199103000-00001","article-title":"Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome","volume":"6","author":"Lynch","year":"1991","journal-title":"Pancreas"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R","article-title":"Characterization of ligurian melanoma families and risk of occurrence of other neoplasia","volume":"83","author":"Ghiorzo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0601273103","article-title":"Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse","volume":"103","author":"Bardeesy","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib39","first-page":"2298","article-title":"Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors","volume":"58","author":"Bahuau","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/1097-0142(19951101)76:9<1571::AID-CNCR2820760912>3.0.CO;2-6","article-title":"Familial cutaneous malignant melanoma and tumours of the nervous system","volume":"76","author":"Azizi","year":"1995","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib41","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archderm.1978.01640170032006","article-title":"Origin of familial malignant melanomas from heritable melanocytic lesions","volume":"114","author":"Clark","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/jmg.20.5.342","article-title":"Familial atypical multiple mole-melanoma (FAMMM) syndrome; segregation analysis","volume":"20","author":"Lynch","year":"1983","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00049406","article-title":"Human cutaneous malignant melanoma as a model for cancer","volume":"10","author":"Clark","year":"1991","journal-title":"Cancer Metastas Rev"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2001.114580","article-title":"Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi","volume":"45","author":"Annessi","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1469-1809.1986.tb01046.x","article-title":"Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome","volume":"50","author":"Bergman","year":"1986","journal-title":"Ann Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1523-1747.2000.00823.x","article-title":"Genotype\/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations","volume":"114","author":"Bishop","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/302494","article-title":"A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: A maximum-likelihood combined linkage and association analysis in twins and their sibs","volume":"65","author":"Zhu","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jnci\/92.6.457","article-title":"Genetics of risk factors for melanoma: an adult twin study of nevi and freckles","volume":"92","author":"Bataille","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib50","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.0022-202x.2001.01415.x","article-title":"Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study","volume":"117","author":"Wachsmuth","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib51","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/sj.bjc.6600904","article-title":"Linkage and association analysis of nevus density and the region containing the melanoma gene CDKN2A in UK twins","volume":"88","author":"Barrett","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/sj.ejhg.5201729","article-title":"A genome-wide scan for naevus count: Linkage to CDKN2A and to other chromosome regions","volume":"15","author":"Zhu","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib53","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1093\/hmg\/ddl227","article-title":"Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort","volume":"15","author":"Falchi","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(02)00894-X","article-title":"Genetic testing for melanoma","volume":"3","author":"Kefford","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001622-200303000-00007","article-title":"Is there a role for genetic testing in patients with melanoma?","volume":"15","author":"Kefford","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib56","series-title":"Cancer Incidence in Five Continents","author":"Parkin","year":"1997"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib57","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/exer.1998.0599","article-title":"The pink-eyed dilution locus controls the biogenesis of melanosomes and levels of melanosomal proteins in the eye","volume":"68","author":"Orlow","year":"1999","journal-title":"Exp Eye Res"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib59","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1091\/mbc.02-02-0022.","article-title":"Pink-eyed dilution protein controls the processing of tyrosinase","volume":"13","author":"Chen","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib61","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/hmg\/10.16.1701","article-title":"The melanocortin-1-receptor gene is the major freckle gene","volume":"10","author":"Bastiaens","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype?","volume":"66","author":"Palmer","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib63","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/jmg.2003.011536","article-title":"Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure","volume":"41","author":"Matichard","year":"2003","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib64","first-page":"A200","article-title":"Melanocortin 1 receptor (MC1R) variant Arg151Cys is generally associated with fair skin and modifies risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families","volume":"61","author":"Gruis","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/323411","article-title":"Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma","volume":"69","author":"van der Velden","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib66","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/323412","article-title":"MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations","volume":"69","author":"Box","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib67","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/339076","article-title":"A polymorphism in the agouti signaling protein gene is associated with human pigmentation","volume":"70","author":"Kanetsky","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib68","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/dji176","article-title":"MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population","volume":"97","author":"Landi","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib69","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jdermsci.2005.08.001","article-title":"Association study of the g.8818A>G polymorphism of the human agouti gene with melanoma risk and pigmentary characteristics in a French population","volume":"40","author":"Meziani","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib70","first-page":"782","article-title":"P gene as an inherited biomarker of human eye color","volume":"11","author":"Rebbeck","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/ddh043","article-title":"Interactive effects of MC1R and OCA2 on melanoma risk phenotypes","volume":"13","author":"Duffy","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib72","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.ejhg.5201415","article-title":"Allele variations in the OCA2 gene (pink-eyed-dilution locus) are associated with genetic susceptibility to melanoma","volume":"13","author":"Jannot","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib73","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/ije\/9.3.227","article-title":"Do sunlight and vitamin D reduce the likelihood of colon cancer?","volume":"9","author":"Garland","year":"1980","journal-title":"Int J Epidemiol"},{"issue":"suppl 6","key":"10.1053\/j.seminoncol.2007.09.006_bib75","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.seminoncol.2007.09.006_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pbiomolbio.2006.02.014","article-title":"Vitamin D: Its role in cancer prevention and treatment","volume":"2","author":"Holick","year":"2006","journal-title":"Prog Biophys Mol Biol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775407001820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T12:46:39Z","timestamp":1557146799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775407001820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0093775407001820"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2007.09.006","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}